Hence, careful clinical analysis combined with markers such as TSH levels, thyroid antibodies (e.g., TPO antibodies), and ultrasonography, as highlighted in population-based cohort studies, can guide clinicians in deciding whether to treat SCH. Here, TPO is linked to spindle cell hemangioma.